EMA recommends marketing authorization for donanemab (Kisunla)
This announcement reverses an earlier recommendation made by the EMA regarding donanemab as a treatment for the treatment of early symptomatic Alzheimer's disease in adults.
News
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
Featured news
The 78th World Health Assembly agrees to extend the Global Action Plan on the Public Health Response to Dementia
The 78th World Health Assembly has been a whirlwind week for ADI as, after 18-months of advocacy, the World Health Assembly has agreed to extend the Global Action Plan on the Public Health Response to Dementia by 6-years, to 2031.
Deputies’ Health and Budget Commissions build momentum towards Argentina’s Dementia National Plan – One Step Closer to Becoming Law
On 13 August, Argentina’s Health and Budget Committees approved the Dementia Bill, marking a major step towards the country’s first National Dementia Plan. Congressman and neuroscientist Facundo Manes urged the government to allocate funding for the law, which now moves to the full Chamber of Deputies before reaching the Senate. ADI welcomes this development as Argentina advances towards making dementia a national health priority.
Strengthening Dementia Advocacy in Mexico: ADI Advances Strategic Partnerships for National Implementation
As part of ADI's ongoing regional commitment to dementia policy, Diego Aguilar, Regional Director for the Americas, completed a high-impact country visit to Mexico that combined academic engagement, civil society coordination, and high-level government and industry dialogue.
Dementia advocacy in the Americas: Strengthening policy and public awareness
From in-person high level engagements in Lima to Buenos Aires, to a digital campaign partnership providing regionally specific resources, May has proven to be an action-packed month in the Americas region. ADI Regional Director for the America’s provides his highlights from across the region including advocacy work in Argentina and Peru, alongside a public awareness campaign in partnership with the Carlos Slim Foundation.
Argentina Takes a Historic Step Toward a National Dementia Plan
On 29 April 2025, ADI Regional Director for the Americas, Diego Aguilar attended the Symposium on Brain Health Promotion: Towards a National Dementia Plan in Buenos Aires, Argentina, during which key political figures, international experts, civil society leaders, and advocates joined the call for the urgent approval of Argentina’s first National Dementia Plan.
ADI driving action in the Americas: Developing dementia care policies in Argentina, Curaçao and Mexico
In March 2025, ADI was involved in a range of engagements across the Latin American region, from high level symposiums in Curaçao and Mexico, to providing strategic input on draft bills in Argentina and the international bloc of Latin American countries MERCOSUR.
ADI staff explore the current landscape of dementia research and innovation
This month, ADI CEO Paola Barbarino and ADI Director of Research and Publications, Wendy Weidner, travelled to the East Coast of the United States to meet with leading researchers, universities, and industry innovators to discuss recent advancements in the research and innovation sphere of dementia care.
Spotlight on the Americas: ADI’s Activities in Peru and Chile
In February, ADI representatives took part in two important events in the Americas showcasing the great progress currently being made in the region.ADI Board Member Rosa Farrés attended a workshop in Peru on Advancing Brain Health, hosted by the Global Brain Health Institute at the beginning of the month. Then, ADI Regional Director for the Americas, Diego Aguilar, visited Chile to attend the Alzheimer’s Association International Conference (AAIC) Neuroscience Next conference, building on Chile’s recent efforts on the updating of their National Dementia Plan strategy.